Apellis Pharmaceuticals (APLS) Q1 2023 Earnings

4MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-1.75
-1.62
-1.49
-1.36

Details

Expected EPS
-1.46
Actual EPS
-1.56
Surprise EPS
-0.1
Surprise Percent
+6.85%

Description

Apellis Pharmaceuticals (APLS) has reported earnings of -1.56 per share for Q1 2023.

0 Comments

Share your thoughts